{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-063627","form_type":"8-K","ticker":"ABVC","cik":"0001173313","company_name":"ABVC BIOPHARMA, INC.","filed_at":"2024-07-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.335991+00:00","generated_at":"2026-05-31T17:49:17.414485+00:00","sec_items":["5.02","8.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"ABVC BioPharma CFO suspends work amid salary dispute; company corrects license fee numbers downward","bullets":["CFO Leeds Chow suspends work due to disagreements over salary owed; CEO Uttam Patil becomes interim CFO.","Potential aggregate license fee corrected from $24M to $19M in prior press release.","Total possible cash payment from licensees corrected from $23.7M to $18.7M.","Disagreement limited to salary; not related to public filings disclosures."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-063627","json":"https://secwatch.observer/filing/0001213900-24-063627.json","markdown":"https://secwatch.observer/filing/0001213900-24-063627.md","text":"https://secwatch.observer/filing/0001213900-24-063627.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1173313/000121390024063627/0001213900-24-063627-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1173313/000121390024063627/ea020990501-8k_abvcbio.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T17:49:17.414485+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"504baa8963","claim":"Leeds Chow departed as Chief Financial Officer at ABVC BIOPHARMA, INC..","evidence_excerpt":"due to disagreements regarding salaries due and payable, Mr. Chow has informed the Company that he is suspending his work as CFO.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1173313/000121390024063627/0001213900-24-063627-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"suspending his work"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"ed8d04c81f","claim":"Uttam Patil was appointed as interim Chief Financial Officer at ABVC BIOPHARMA, INC..","evidence_excerpt":"The Company’s CEO, Uttam Patil, will assume the duties of interim Chief Financial Officer until the parties settle the disagreement and Leeds resumes his position as CFO.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1173313/000121390024063627/0001213900-24-063627-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"assume the duties of interim Chief Financial Officer"},{"label":"Role","value":"interim Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}